| Effect | Decrease |
| Values | −1.8 ± 2.5 chromium vs. −0.2 ± 0.8 placebo in Ferriman Gallwey scores. , P = 0.002 |
| Trial Design | Randomized trial |
| Trial Length | 1-6 months |
| Number of Subjects | 60 |
| Gender | Female |
| Age Range | 18-29, 30-44 |
60 woman with PCOS were given either placebo or 200 µg chromium picolinate for 8 weeks. Chromium reduced acne, hirsutism, and C-reactive protein and improved plasma total antioxidant capacity but no change in reproductive hormones (FSH, LH, prolactin, and free testosterone).
